Rapid Micro Biosystems (NASDAQ: RPID) — Perfil da empresa, notícias e dados financeiros
Rapid Micro Biosystems offers automated microbial detection solutions for life sciences, enhancing quality control in manufacturing.
Rapid Micro Biosystems
Rapid Micro Biosystems (NASDAQ:RPID) specializes in providing innovative solutions aimed at automating the microbial detection and enumeration process for pharmaceutical and personal care products manufacturing. Their main focus is on enhancing productivity, quality, and compliance within the life sciences industry through their flagship product, the Growth Direct™ system. This system revolutionizes traditional microbial quality control methods by significantly reducing the time needed to detect contamination, thereby accelerating product release times and improving manufacturing efficiency. Rapid Micro Biosystems' objective is to disrupt the conventional microbial testing market by bringing speed, accuracy, and data integrity to quality control laboratories worldwide, ultimately ensuring safer products reach consumers more quickly.
Resumo
Operações
Produtos e/ou serviços de Rapid Micro Biosystems
- The Growth Direct system automates rapid microbial detection, enhancing pharmaceutical manufacturing efficiency and safety through faster quality control testing.
- Environmental Monitoring applications of the Growth Direct system provide automated, rapid detection of environmental contaminants in manufacturing areas, ensuring compliance with regulatory standards.
- Sterility Testing solutions by the Growth Direct system offer rapid, automated testing for pharmaceutical products, significantly reducing the time to release sterile products to market.
- Bioburden Testing services utilize the Growth Direct system for fast, automated detection of microbial contamination in raw materials, in-process samples, and finished products.
- Data Management and Reporting tools integrated with the Growth Direct system offer real-time, efficient data analysis and reporting capabilities, improving decision-making and compliance.
- Service and Support for the Growth Direct system ensure optimal performance and uptime, including installation, training, maintenance, and troubleshooting, enhancing customer satisfaction and trust.
equipe executiva do Rapid Micro Biosystems
- Robert G. Spignesi Jr.CEO, President, COO & Director
- Sean M. WirtjesChief Financial Officer
- Michael BeaulieuVice President of Investor Relations & Corporate Communications
- James XuSenior VP of Legal & Secretary
- Katherine AtkinsonSenior VP of Global Sales & Marketing
- Julie JarvieSenior VP of Human Resources
- Chris RobinsonSenior Vice President of Operations
Principais indicadores financeiros
Resultados divulgados pela Rapid Micro Biosystems, em USD.
- Cap. de mercado
- 39,5 mi
- Receita (TTM)
- 35,2 mi
- P/L
- —
- LPA (diluído, TTM)
- -1.1
- Dividend yield
- —
- Margem de lucro
- -145.6%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 33,6 mi | -47,4 mi | -47,1 mi | |
| 28,1 mi | -49,9 mi | -46,9 mi | |
| 22,5 mi | -56,6 mi | -52,5 mi | |
| 17,1 mi | -63,2 mi | -60,8 mi |